Goldman Urology Clinic recently demonstrated its treatment capabilities by achieving a cumulative total of 6,000 benign prostatic hyperplasia (BPH) surgeries. This achievement is evaluated as the result of applying customized treatment strategies optimized for each patient's condition, based on a wide range of BPH surgical options.
Benign prostatic hyperplasia (BPH) is known as a common disease among middle-aged and elderly men. It is characterized by the prostate gland becoming excessively enlarged and compressing the urethra, leading to lower urinary tract symptoms (LUTS) such as frequent urination, nocturia (nighttime urination), a sensation of incomplete bladder emptying, and delayed urination. In the early stages of BPH, symptoms can be managed with medication. However, if the response to medication decreases or symptoms recur and worsen, surgical treatment becomes necessary. At this point, it is crucial to guide the patient in selecting the most appropriate surgical technique, taking into comprehensive consideration not only the size and shape of the prostate but also symptoms, presence of complications, chronic diseases, anesthesia conditions, and recovery plans.
In accordance with these treatment principles, Goldman Urology Clinic has strived to introduce the latest surgical techniques and refine its clinical protocols. The clinic has expanded its spectrum of available treatments, allowing selection based on the patient's condition. This includes the Rezum procedure, which injects high-temperature steam to necrotize and shrink hypertrophied tissue; Aquablation (Waterjet Robotic Surgery), which uses a high-pressure AI robot waterjet to precisely resect prostate tissue without thermal damage; and HoLEP (Holmium Laser Enucleation of the Prostate) surgery, which completely removes hypertrophied tissue using a holmium laser.
Furthermore, by operating various methods together, such as iTind, which widens the prostatic urethra, and UroLift, which minimizes the burden of surgical resection, the clinic has established customized treatment strategies based on the patient's prostate size, shape, and symptom severity.
Moreover, Goldman Urology Clinic continues its ongoing research into BPH, based on over 2 million clinical data points accumulated over more than 20 years. These research achievements accumulate as clinical outcomes in actual practice, leading to positive evaluations. In fact, based on its clinical experience with waterjet robotic surgery, the clinic has presented relevant research findings at academic conferences and has verified and refined the safety and efficacy of the latest surgical techniques in real clinical settings.
Dr. Lee Chang-ki, Chief Director of Goldman Urology Clinic, stated, “The outcome of BPH surgery inevitably varies depending on the medical team's proficiency, the accuracy of pre-operative evaluation, and the post-operative management system. The medical staff across all branches of Goldman Urology Clinic have enhanced treatment consistency and stability through a system that periodically shares clinical data and jointly develops treatment protocols.” He added, “Especially for BPH, since each patient experiences discomfort differently, and concomitant diseases or recovery plans also vary, our core principle is an approach that offers the necessary surgical technique at the time it is needed for the patient, rather than fixing on one method as the sole correct answer.”